| Target Price | €29.58 |
| Price | €20.15 |
| Potential |
46.80%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target M1 Kliniken 2027 .
The average M1 Kliniken target price is €29.58.
This is
46.80%
register free of charge
€31.50
56.33%
register free of charge
€28.28
40.35%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend M1 Kliniken to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the M1 Kliniken stock has an average upside potential 2027 of
46.80%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 364.30 | 269.47 |
| 7.41% | 26.03% | |
| EBITDA Margin | 10.99% | 12.37% |
| 17.89% | 12.52% | |
| Net Margin | 6.07% | 8.32% |
| 28.61% | 36.96% |
3 Analysts have issued a sales forecast M1 Kliniken 2026 . The average M1 Kliniken sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an M1 Kliniken EBITDA forecast 2026. The average M1 Kliniken EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 M1 Kliniken Analysts have issued a net profit forecast 2026. The average M1 Kliniken net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 1.13 | 1.19 |
| 37.80% | 5.31% | |
| P/E | 16.87 | |
| EV/Sales | 1.17 |
3 Analysts have issued a M1 Kliniken forecast for earnings per share. The average M1 Kliniken EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 12 2026 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 12 2026 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Feb 27 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


